MORGAN STANLEY

Position in NBIX — Neurocrine Biosciences Inc

CIK 895421 NEW YORK, NY

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$160,616,870

-$10,909,204 QoQ

Shares Held

1,219,196

+0.8% QoQ

Ownership

1.21%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 90.61365030725167.ToString("F0")% Shared 0.ToString("F0")% None 9.386349692748336.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $4,148,184,090 across 73 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	14,145,735	$1,672,167,321
2	UTHR	UNITED THERAPEUTICS Corp	409,288	$242,699,592
3	TEVA	Teva Pharmaceutical Industries Ltd	7,426,253	$223,678,734
4	VTRS	Viatris Inc	16,089,939	$217,375,067
5	HLN	Haleon plc	19,166,253	$191,854,187
6	HIMS	Hims & Hers Health, Inc.	8,889,088	$184,537,462
7	NBIX	Neurocrine Biosciences Inc This page	1,219,196	$160,616,870
8	ELAN	Elanco Animal Health Inc	6,417,527	$153,571,413

All Filings in NBIX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$160,616,870	1,219,196	+0.8%	Shares	Defined	2026-05-15
2025-12-31	$171,526,074	1,209,378	-33.8%	Shares	Defined	2026-05-27
2025-09-30	$256,465,408	1,826,937	+0.4%	Shares	Defined	2026-05-27
2025-06-30	$228,723,739	1,819,745	+19.9%	Shares	Defined	2025-08-15
2025-03-31	$167,917,004	1,518,237	-3.5%	Shares	Defined	2025-05-15
2024-12-31	$214,755,037	1,573,297	+16.6%	Shares	Defined	2025-05-15
2024-09-30	$155,475,671	1,349,381	-12.7%	Shares	Defined	2025-05-14
2024-06-30	$212,682,108	1,544,869	-25.2%	Shares	Defined	2025-05-14
2024-03-31	$284,892,508	2,065,636	-11.2%	Shares	Defined	2024-10-17
2023-12-31	$306,512,492	2,326,294	+20.9%	Shares	Defined	2024-08-16
2023-09-30	$216,458,885	1,924,079	+3.0%	Shares	Defined	2023-11-15
2023-06-30	$176,154,750	1,868,025	+12.9%	Shares	Defined	2023-08-14
2023-03-31	$167,508,262	1,654,893	-19.2%	Shares	Defined	2023-05-15
2022-12-31	$244,623,266	2,048,085	+281.6%	Shares	Defined	2023-02-14
2022-09-30	$57,011,186	536,778	+10.2%	Shares	Defined	2022-11-14
2022-06-30	$47,499,562	487,275	+175.6%	Shares	Defined	2022-10-27
2022-03-31	$16,577,528	176,827	+26.9%	Shares	Defined	2022-10-27
2021-12-31	$11,869,714	139,365	-3.8%	Shares	Defined	2022-02-14
2021-09-30	$13,896,492	144,891	-58.6%	Shares	Defined	2021-11-15
2021-06-30	$34,023,069	349,600	+217.2%	Shares	Defined	2021-08-23
2021-03-31	$10,718,601	110,217	-11.9%	Shares	Defined	2021-05-17
2020-12-31	$11,988,245	125,073	-55.8%	Shares	Defined	2021-02-16
2020-09-30	$27,230,778	283,182	+94.4%	Shares	Defined	2020-11-13
2020-06-30	$17,772,838	145,679	+78.9%	Shares	Defined	2020-08-14
2020-03-31	$7,047,851	81,431	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.